The
primary factor driving this market is the rising outspread of bacteria causing
meningococcal meningitis like A, B, C, W, X and Y. The outbreak of this disease
irrespective of age and rapid transmission across geographical boundaries
coupled with its adverse long term effect of this disease especially in
children is bolstering this market. The support provided by the government and
various regulatory organizations for campaigning and spreading awareness
regarding this disease like ‘Defeating meningitis by 2030’, national
immunization programs and many more. Other factors including increasing
traveling to sub-Saharan Africa and the necessity to undertake meningococcal
vaccination are propelling this market. However, lack of mandatory regulation
to undertake this vaccine in many countries and rigid directives of regulatory
bodies for the approving new vaccines is straining this market. However,
research and development in this field and the development of the healthcare
infrastructure is expected to open up new avenues for this market.
The
global Meningococcal Vaccines market size is projected to reach US$ 6802.91
million by 2028, from US$ 3339.9 million in 2020, at a CAGR of 9.3% during
2021-2028.
In
terms of production side, this report researches the Meningococcal Vaccines
production capacity, value, ex-factory price, growth rate, market share by
manufacturers, regions (or countries) and by Type.
In
terms of consumption side, this report focuses on the consumption of Meningococcal
Vaccines by regions (countries) and by Application.
The
global Meningococcal Vaccines market is thoroughly, accurately, and
comprehensively assessed in the report with a large focus on market dynamics,
market competition, regional growth, segmental analysis, and key growth strategies.
Buyers of the report will have access to verified market figures, including
global market size in terms of revenue and volume. As part of production
analysis, the authors of the report have provided reliable estimations and
calculations for global revenue and volume by Type segment of the global Meningococcal
Vaccines market. These figures have been provided in terms of both revenue and
volume for the period 2016-2028. Additionally, the report provides accurate
figures for production by region in terms of revenue as well as volume for the
same period. The report also includes production capacity statistics for the
same period.
Geographic Segmentation
The
report offers exhaustive assessment of different region-wise Meningococcal
Vaccines markets such as North America, Europe, China and Japan, etc. Key
regions covered in the report are U.S., Canada, Germany, France, U.K., Italy,
Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia,
Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia,
U.A.E
For
the period 2016-2028, the report provides country-wise revenue and volume sales
analysis and region-wise revenue and volume analysis of the global Meningococcal
Vaccines market. For the period 2020-2028, it provides sales (consumption)
analysis and forecast of different regional markets by each application as well
as type segment in terms of volume.
Manufacturers
The
report includes comprehensive company profiling of leading and emerging
companies competing in the global Meningococcal Vaccines market. It provides a
detailed list of players operating at a global level. The players have been
listed according to the type of products they offer in the global Meningococcal
Vaccines market and other factors. As part of the company profiling, the
analysts authoring the report has provided the market entry year of each player
considered for the research study. The report also offers extensive price,
volume sales, and revenue analysis by the manufacturer at the global level for
the period 2016-2028.
By Type and Application
Segments
The
report includes a detailed analysis of leading and type and application
segments of the global Meningococcal Vaccines market. All of the segments
covered in the report are broadly analyzed based on some deciding factors. The
segmental analysis section of the report offers revenue sales analysis and
forecast of the global Meningococcal Vaccines market by each type segment for
the period 2016-2028. It also offers volume sales (consumption) analysis and forecast
of the global Meningococcal Vaccines market by each type segment for the same
period. Also, it provides volume sales (consumption) analysis and forecast of
the global Meningococcal Vaccines market by each application segment for the
same period.
This report includes the
following manufacturers:
Baxter
International Inc
Biomed
Pvt Ltd
GlaxoSmithKline
Plc
JN-International
Medical Corporation
Novartis
International AG
Pfizer
Inc
Sanofi
SA
Serum
Institute of India Ltd
Walvax
Biotechnology Co Ltd
Incepta
Pharmaceuticals Ltd
Market
Segment by Vaccine Serotype
MenACWY
MenB
and Manic
MenC
MenA
MenAC
Market
Segment by Vaccine
Conjugate
Polysaccharide
Subcapsular
Market
Segment by Age Group
Infants
Children
Adolescents
& Young Adults
Adults
Market
Segment by Distribution Channel
Pharmacies
Community
Clinics
Public
Health Agencies
Others
Research Methodology
To
compile the detailed study of the global Meningococcal Vaccines market, a
robust research methodology has been adopted that aids in determining the key
insights and also evaluates the growth prospects of the Meningococcal Vaccines
market. Data Insights Partner Research analysts have conducted in-depth primary
and secondary research to obtain crucial insights into the Meningococcal
Vaccines market. To carry out secondary research, the analysts have collected
the information through company annual reports, journals, company press
releases, and paid databases that were referred to gain and identify better
opportunities in the global market.
Salient Features:
Ø
This study offers
comprehensive yet detailed analysis of the Meningococcal
Vaccines market, size of the
market (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the period of
forecast: 2020-2028, taking into account 2019 as the base year
Ø
It explains upcoming
revenue opportunities across various market segments and attractive matrix of
investment proposition for the said market
Ø
This market
intelligence report also offers pivotal insights about various market opportunities,
restraints, drivers, competitive market strategies of leading market players,
emerging market trends, and regional outlook
Ø
Profiling of
key market players in the world Meningococcal Vaccines market is done by taking into account various parameters such
as company strategies, distribution strategies, product portfolio, financial
performance, key developments, geographical presence, and company overview
Ø
The data of
this report would allow management authorities and marketers of companies alike
to take informed decision when it comes to launch of Type of models, government
initiatives, marketing tactics and expansion, and technical up gradation
Ø
The world
market for Meningococcal Vaccines caters to the needs of various stakeholders pertaining to this
industry, namely suppliers, manufacturers, investors, and distributors for Meningococcal
Vaccines market. The research
also caters to the rising needs of consulting and research firms, financial
analysts, and new market entrants
Ø
Research
methodologies that have been adopted for the purpose of this study have been
clearly elaborated so as to facilitate better understanding of the reports
Ø
Reports have
been made based on the guidelines as mandated by General Data Protection
Regulation
Ø
Ample number
of examples and case studies have been taken into consideration before coming
to a conclusion
Reasons to buy:
v
Identify
opportunities and plan strategies by having a strong understanding of the investment
opportunities in the Meningococcal Vaccines market
v
Identification
of key factors driving investment opportunities in the Meningococcal
Vaccines market
v
Facilitate
decision-making based on strong historic and forecast data
v
Position
yourself to gain the maximum advantage of the industry’s growth potential
v
Develop
strategies based on the latest regulatory events
v
Identify key
partners and business development avenues
v
Respond to
your competitors’ business structure, strategy and prospects
v
Identify key
strengths and weaknesses of important market participants